MRI-Guided Cryoablation of In-Transit Metastases from Cutaneous Melanoma: A Brief Report on a Preliminary Experience

Cardiovasc Intervent Radiol. 2017 Aug;40(8):1285-1289. doi: 10.1007/s00270-017-1645-x. Epub 2017 Apr 4.

Abstract

This study aims to discuss MRI-guided cryoablation (CA) of in-transit (IT) metastases from melanoma and to retrospectively present our preliminary experience in such a specific field. Three female patients (mean age 55.6 years; range 39-64) were included, and eight IT metastases (mean size 12.4 ± 6.5 mm, range: 5-25) were treated in three different sessions. Technical success was 100%; and mean procedural time 129.3 ± 103 min. (range 42-243). Primary local tumour control was 100% at 1-, 6- and 12-month follow-up; and 87.5% at 18-month follow-up. Two complications were recorded (one minor and one major). MRI-guided CA is a novel therapy, which may be included in the armamentarium of local therapies of IT metastases.

Keywords: Cryoablation; In-transit metastases; MRI; Melanoma.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Cryosurgery / methods*
  • Female
  • Humans
  • Lymphatic Metastasis / diagnostic imaging*
  • Lymphatic Metastasis / pathology
  • Magnetic Resonance Imaging / methods*
  • Male
  • Melanoma / diagnostic imaging
  • Melanoma / secondary*
  • Melanoma / surgery*
  • Middle Aged
  • Positron Emission Tomography Computed Tomography
  • Retrospective Studies
  • Skin Neoplasms / diagnostic imaging
  • Skin Neoplasms / secondary*
  • Skin Neoplasms / surgery*
  • Subcutaneous Tissue / diagnostic imaging
  • Subcutaneous Tissue / surgery
  • Surgery, Computer-Assisted / methods*